Abstract. The phytocomponent p-hydroxycinnamic acid (HCA) has been shown to have inhibitory effects on boneresorbing factor-stimulated bone resorption in rat femoral tissues in vitro. The effects of HCA on osteoclast-like cell formation in mouse bone marrow cultures in vitro were investigated. The bone marrow cells were cultured for 7 days in ·-minimal essential medium containing a bone-resorbing agent [parathyroid hormone (1-34)] (PTH), prostaglandin E 2
Introduction
Aging induces a decrease in bone mass (1, 2) . Osteoporosis with its accompanying decrease in bone mass is widely recognized as a major public health problem. The most dramatic expression of the disease is represented by fractures of the proximal femurs (3, 4) . Bone loss with aging may be due to decreased bone formation and increased bone resorption. Pharmacological and nutritional factors may prevent bone loss with aging (5, 6) . Chemical compounds in food and plants that act on bone metabolism, however, are poorly understood.
Recent studies have shown that isoflavones (7, 8) , which are contained in soybean, and menaquinone-7 (9, 10) , an analogue of vitamin K 2 which is essential for the Á-carboxylation of osteocalcin of bone matrix protein (11) and abundant in fermented soybean, have stimulatory effects on osteoblastic bone formation and inhibitory effects on osteoclastic bone resorption, thereby increasing bone mass. Of the various carotenoids (including ß-cryptoxanthin, lutein, lycopene, and ß-carotene), which are present in fruit and vegetables, ß-cryptoxanthin has been found to have unique anabolic effects on bone calcification (12, 13) . ß-Cryptoxanthin has stimulatory effects on osteoblastic bone formation (14) and inhibitory effects on osteoclastic bone resorption (15) in vitro. The supplementation of isoflavones, menaquinone-7 and ß-cryptoxanthin has preventive effects on bone loss induced by ovariectomy in rats, which are an animal model of osteoporosis (16) (17) (18) . Chemical factors in food and plants thus play a role in bone health and may be important in the prevention of bone loss with aging.
Cinnamic acid is present in many plants. p-Hydroxycinnamic acid is an intermediate-metabolic substance in plants, and is synthesized from thyrosine. Recently, it has been found that among cinnamic acid and other related compounds, p-hydroxycinnamic acid (HCA) has unique anabolic effects on bone components (19, 20) . HCA has stimulatory effects on bone formation and inhibitory effects on bone resorption in rat femoral tissues in vitro (19) . HCA may have a role in the prevention of osteoporosis with aging.
This study, moreover, was undertaken to determine whether HCA has inhibitory effects on osteoclastic cell formation. We found that HCA inhibits various bone-resorbing factor-induced osteoclast-like cell formation in mouse bone marrow cultures in vitro.
Materials and methods
Chemicals. ·-Minimal essential medium (·-MEM) and penicillin-streptomycin (5000 U/ml penicillin, 5000 μg/ml streptomycin) were obtained from Gibco Laboratories. Fetal bovine serum was obtained from Bioproducts Inc. Synthetic human parathyroid hormone (1-34, PTH), prostaglandin E 2 (PGE 2 ), tumor necrosis factor-· (TNF-·), receptor activator of NF-κB ligand (RANKL, mouse), macrophage colonystimulating factor (M-CSF, mouse), phorbol 12-myristate 13-acetate (PMA), dibutyryl cyclic adenosine monophosphate (DcAMP), cycloheximide, and 5,6-dichloro-1-ß-D-ribofuranosylbenzimidazole (DRB) were obtained from Sigma Chemicals (St. Louis, MO, USA). p-Hydroxycinnamic acid (HCA), and other chemicals were obtained from Wako Pure Chemical Industries (Osaka, Japan). Chemicals were dissolved in distilled water or ethanol (99.5%).
Animals. Male mice (ddY strain, 6 weeks old) were obtained from Japan SLC (Hamamatsu, Japan). The animals were fed commercial laboratory chow (solid) containing 1.1% phosphorus and 0.012% zinc, and were given distilled water. Mice were sacrificed by exsanguination.
Marrow cultures. Bone marrow cells were isolated from the mice, as reported elsewhere (21, 22) . Briefly, bone ends of the femur were cut off, and the marrow cavity was flushed with 1 ml of ·-MEM. The marrow cells were washed with ·-MEM and cultured in the same medium containing 10% heatinactivated fetal bovine serum with 1.0x10 7 cells/ml in 24-well plates (0.5 ml/well) in a water-saturated atmosphere containing 5% CO 2 and 95% air at 37˚C. The cells were cultured for 3 days, then 0.2 ml of the old medium was replaced with fresh medium, and the cultured cells were maintained for an additional 4 days. Various concentrations of HCA were added to the culture medium containing either vehicle, PTH (10 -7 M), PGE 2 (10 -5 M), or TNF-· (10 ng/ml) in effective concentrations at the beginning of the cultures and at the time of medium change. In separate experiments, the respective media contained either vehicle, M-CSF (10 ng /ml) plus RANKL (10 ng/ml), PMA (10 -6 M) or DcAMP (10 -5 M). After being cultured for 7 days, cells adherent to the 24-well plates were stained for tartrate-resistant acid phosphatase (TRACP), a marker enzyme of osteoclasts (23, 24) .
Enzyme histochemistry. Cultured cells adherent to the 24-well plates were stained for TRACP. Briefly, cells were washed with Hanks' balanced salt solution and fixed with 10% neutralized formalin-phosphate (pH 7.2) for 10 min. After the culture dishes were dried, TRACP-staining was applied according to the method of Burstone (23) . The fixed cells were incubated for 12 min at room temperature (25˚C) in an acetate buffer (pH 5.0) containing both naphthol AS-MX phosphate (Sigma) as a substrate and red violet LB salt (Sigma) as a stain for the reaction product in the presence of 10 mM sodium tartrate (23) . TRACP-positive multinucleated cells (MNCs) containing three or more nuclei were counted as osteoclast-like cells.
Statistical methods. Data were expressed as the mean ± SEM. Statistical differences were analyzed using Student's paired t-test. We also used a multiple ANOVA to compare the treatment groups. A p value <0.05 was considered to indicate a statistically significant difference.
Results

Effects of p-hydroxycinnamic acid (HCA) on bone-resorbing factor-induced osteoclast-like cell formation in bone marrow cell cultures.
The effect of HCA on bone-resorbing factorinduced osteoclast-like MNC formation in the mouse bone marrow culture system was examined (25) (26) (27) . Mouse bone marrow cells were cultured for 7 days in medium containing either vehicle, PTH (10 -7 M), PGE 2 (10 -5 M), or TNF-· (10 ng/ ml) in the presence or absence of HCA (10 -8 -10 -5 M). The number of TRACP-positive MNCs was significantly increased in the presence of PTH (Fig. 1A) , PGE 2 ( Fig. 2A) , or TNF-· (10 ng/ml) (Fig. 3A) . TRACP-positive MNCs were not appreciably formed in the control culture without boneresorbing factors at any incubation time. The presence of HCA (10 -8 -10 -5 M) in the culture medium caused a significant decrease in the number of TRACP-positive MNCs stimulated by PTH (Fig. 1B) , PGE 2 ( Fig. 2B ), or TNF-· (Fig. 3B) . HCA in the range of 10 -8 -10 -5 M did not have an inhibitory effect on the proliferation of bone marrow cells. This was independent of the presence of bone-resorbing factors (data not shown).
In another experiment, mouse bone marrow cells were cultured for 3 days in medium containing either vehicle, PTH (10 -7 M), or PGE 2 (10 -5 M). HCA (10 -6 or 10 -5 M) was added to the culture medium containing each bone-resorbing agent, and the cells were incubated for an additional 4 days. In this case, the presence of HCA caused a significant inhibition of osteoclast-like MNC formation induced by bone-resorbing agents (Fig. 4) .
Effects of HCA on intracellular signaling factor-induced osteoclast-like cell formation in bone marrow cell cultures.
The effect of DcAMP or PMA on osteoclast-like MNC formation in mouse bone marrow culture was examined. The effect of PTH or PGE 2 is mediated through cyclic AMP (28, 29) . PMA is an activator of protein kinase C, which is related to intracellular Ca 2+ signaling (30) . Mouse bone marrow cells were cultured for 7 days in medium containing either vehicle, DcAMP (10 -5 M), or PMA (10 -6 M) in an effective concentration in the presence or absence of HCA (10 -6 or 10 -5 M). Osteoclast-like cell formation was significantly increased in the presence of DcAMP or PMA (Fig. 5) . The effect of DcAMP or PMA was significantly inhibited by the addition of HCA (10 -6 or 10 -5 M) (Fig. 5) . 
Effect of HCA on RANKL-induced osteoclast-like cell formation in bone marrow cell cultures.
The effect of HCA on RANKL plus M-CSF-induced osteoclast-like MNC formation in mouse bone marrow culture was examined. RANKL and M-CSF are critical cytokines that stimulate osteoclast differentiation (31, 32) . Mouse bone marrow cells were cultured for 7 days in medium containing either vehicle or RANKL plus M-CSF at 10 ng/ml of medium in the presence or absence of HCA (10 -8 -10 -5 M). The number of TRACP-positive MNCs was markedly increased in the presence of RANKL plus M-CSF (Fig. 6A) . The presence of HCA (10 -8 -10 -5 M) in the culture medium caused a significant inhibition of osteoclast-like MNC formation induced by the cytokines (Fig. 6B) .
The effect of HCA on RANKL plus M-CSF-induced osteoclast-like MNC formation in mouse bone marrow cultures was examined in the presence of cycloheximide, an inhibitor of the transcriptional process, and DRB, an inhibitor of transcription. To note, the presence of DRB (10 -6 M) caused a significant increase in TRACP-positive MNC formation in the presence of RANKL plus M-CSF (10 ng/ml) (Fig. 7C) . RANKL plus M-CSF-induced osteoclast MNC formation was also seen in the presence of cycloheximide (10 -7 M) (Fig. 7B) . The effect of HCA in inhibiting RANKL plus M-CSF-induced TRACP-positive HNC formation was not seen in the presence of cycloheximide or DRB (Fig. 7) 
Discussion
The effects of cinnamic acid and other related phytocomponent compounds on bone metabolism have not yet been elucidated. More recently, we have found that p-hydroxycinnamic acid (HCA) stimulates bone formation and inhibits boneresorbing factor-induced bone resorption in vitro (19) , and that the oral administration of HCA has anabolic effects on bone components in the femoral tissues of rats in vivo (20) . This study, moreover, demonstrates that HCA has an inhibitory effect on various bone-resorbing factor-induced osteoclast-like cell formation in mouse bone marrow cultures in vitro. This finding supports the view that HCA inhibits osteoclastic bone resorption in vitro.
Culture with HCA caused a significant inhibition of PTH-PGE 2 -, or TNF-·-induced osteoclast-like cell formation in mouse bone marrow cultured in vitro. HCA did not have an effect on the proliferation of bone marrow cells (data not shown), showing that HCA did not have a toxic effect on the cells. The inhibitory effect of HCA on osteoclast-like cell formation was observed to a greater extent at the earlier stage of osteoclast differentiation in bone marrow cultures. However, its inhibitory effect was also observed at the later stage of osteoclastogenesis. HCA has an effect on the process of differentiation from mononuclear osteoclast to osteoclast.
RANKL acts on osteoclast progenitors, and the cytokine stimulates osteoclast differentiation (31, 33) . RANKL plays a pivotal role in osteoclast differentiation. RANKL expression is induced in osteoblastic factors, such as PTH, PGE 2 , and 1,25-dihydroxyvitamin D 3 , and the combined treatment of hematopoietic cells with M-CSF and the soluble form of RANKL (sRANKL) induced osteoclast differentiation in vitro (34) . The receptor protein RANK is expressed on the surface of osteoclast progenitors (34) . A soluble fragment containing part of the extracellular domain of RANKL (the carboxyterminal half of the protein, amino acids 158-316) is capable of promoting osteoclastogenesis in the presence of M-CSF. The supporting cells (osteoblasts or stromal cells) are not required for the activity (35) . HCA significantly inhibited osteoclast-like cell formation induced by PTH or PGE 2 . Presumably, the inhibitory effect of HCA is partly involved in RANKL expression and/or RANKL action which are related to the effect of PTH or PGE 2 .
TNF-· is an autocrine factor in osteoclasts, promoting their differentiation, and mediating RANKL's induction of osteoclastogenesis (27) . TNF-· has also been shown to mediate via its p55 receptor in lypoplosaccaride-stimulated osteoclastogenesis (36) . TNF-·-induced osteoclast-like cell formation in mouse bone marrow cultures was significantly inhibited by HCA. The inhibitory effect of HCA on TNF-·-stimulated osteoclastogenesis is probably the combination of effects by locally produced RANKL and TNF-·.
The interaction of RANKL with its receptor RANK leads to the recruitment of the signaling adaptor molecules TRAFs (TNF receptor-associated factors) to the receptor complex and the activation of nuclear factor-κ B (NF-κB) and c-Jun N-terminal kinase (JNK) (37) (38) (39) (40) . The protein kinase C family enzyme has a role in the regulation of osteoclast formation and function potentially by participating in the extracellular signal-regulated kinase (ERK) signaling pathway of M-CSF and RANKL (41) . PMA is an activator of protein kinase C (30) . PMA significantly stimulated osteoclast-like cell formation in mouse bone marrow cultures, and the PMA-induced osteoclastogenesis was significantly inhibited by HCA. Moreover, HCA was found to have a significant inhibitory effect on DcAMP-induced osteoclast-like cell formation in mouse bone marrow cultures. Activation of the protein kinase C and protein kinase A pathways leads to increased RANKL effect, and HCA inhibits protein kinase C-or protein kinase A-related RANKL signaling in osteoclastogenesis. It is assumed that HCA has effects on preosteoclasts and/or osteoclasts.
Culture with HCA caused a significant inhibition of RANKL plus M-CSF-induced osteoclast-like cell formation in mouse bone marrow culture in vitro. This finding may support the view that HCA inhibits the binding of RANKL to receptor RANK, and that the compound suppresses RANKL signaling in osteoclastogenesis.
The effect of HCA in inhibiting RANKL plus M-CSFinduced osteoclast-like cell formation in mouse bone marrow cultures was completely blocked in the presence of cycloheximide, an inhibitor of protein synthesis in translational processes. The stimulatory effect of RANKL plus M-CSF on osteoclastogenesis was not inhibited in the presence of cycloheximide, an inhibitor of protein synthesis, or DRB, an inhibitor of transcriptional processes. The stimulatory effect of RANKL plus M-CSF on osteoclastogenesis was not inhibited in the presence of cycloheximide or DRB. To note, the effect of RANKL was significantly enhanced in the presence of DRB. It is speculated that RANKL stimulation on osteoclastogenesis induces a suppressor protein for osteoclastogenesis, which regulates osteoclast differentiation by an autocrine mechanism. Presumably, the inhibitory effect of HCA on osteoclastogenesis is partly involved in newly synthesized protein components which induce suppressor protein. Whether HCA has an effect on the expression of osteoprotegerin (OPG), a regulated suppressor of osteoclast differentiation (31, 33) in osteoblasts, is unknown, however.
The effect of HCA on the apoptosis of osteoclasts has not been clarified. If HCA has a stimulatory effect on the apoptosis of osteoclasts, the chemical may cause a decrease in the number of osteoclasts. This remains to be elucidated.
HCA is present in many plants. The physiological role of HCA has not been clarified. Recently, it has been shown that HCA has stimulatory effects on bone formation and inhibitory effects on bone resorption in rat femoral tissues in vitro (19) , and that the oral administration of HCA has anabolic effects on bone components in the femoral tissues of normal rats (20) . HCA may have a role in the prevention of bone loss with aging.
In conclusion, it has been demonstrated that the phytocomponent p-hydroxycinnamic acid (HCA) has an inhibitory effect on osteoclast-like cell formation induced by various factors in stimulating osteoclastogenesis in mouse bone marrow cultures in vitro. HCA may act as an inhibitor in RANKL stimulation which induces osteoclastogenesis.
